Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study
出版年份 2020 全文链接
标题
Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study
作者
关键词
-
出版物
LANCET INFECTIOUS DISEASES
Volume 21, Issue 4, Pages 546-558
出版商
Elsevier BV
发表日期
2020-11-11
DOI
10.1016/s1473-3099(20)30488-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Serum IgG antibodies to Shigella lipopolysaccharide antigens – a correlate of protection against shigellosis
- (2019) Dani Cohen et al. Human Vaccines & Immunotherapeutics
- Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human
- (2019) Louis-Antoine Barel et al. Human Vaccines & Immunotherapeutics
- Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990–2016
- (2018) Ibrahim A Khalil et al. LANCET INFECTIOUS DISEASES
- Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings: longitudinal analysis of results from the MAL-ED cohort study
- (2018) Elizabeth T Rogawski et al. Lancet Global Health
- A Synthetic Carbohydrate Conjugate Vaccine Candidate against Shigellosis: Improved Bioconjugation and Impact of Alum on Immunogenicity
- (2016) Robert M. F. van der Put et al. BIOCONJUGATE CHEMISTRY
- Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study
- (2016) Mark S. Riddle et al. Clinical and Vaccine Immunology
- Functional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study
- (2016) Avital A. Shimanovich et al. Clinical and Vaccine Immunology
- Association Between Shigella Infection and Diarrhea Varies Based on Location and Age of Children
- (2015) Brianna Lindsay et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development
- (2014) S. Livio et al. CLINICAL INFECTIOUS DISEASES
- Recent trends in the epidemiology of shigellosis in Israel
- (2014) D. COHEN et al. EPIDEMIOLOGY AND INFECTION
- Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a
- (2013) Rezwanul Wahid et al. CLINICAL IMMUNOLOGY
- Shigella flexneriO-antigens revisited: final elucidation of the O-acetylation profiles and a survey of the O-antigen structure diversity
- (2012) Andrei V. Perepelov et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Dynamic aspects of antibody:oligosaccharide complexes characterized by molecular dynamics simulations and saturation transfer difference nuclear magnetic resonance
- (2011) François-Xavier Theillet et al. GLYCOBIOLOGY
- Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children
- (2010) Justen H. Passwell et al. VACCINE
- A Synthetic Carbohydrate-Protein Conjugate Vaccine Candidate against Shigella flexneri 2a Infection
- (2009) A. Phalipon et al. JOURNAL OF IMMUNOLOGY
- Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease
- (2009) Carl E. Frasch et al. VACCINE
- Structures of synthetic O-antigen fragments from serotype 2a Shigella flexneri in complex with a protective monoclonal antibody
- (2008) B. Vulliez-Le Normand et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started